These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 6977838)
1. HLA B27 in the population of northern Sweden. Bjelle A; Cedergren B; Dahlqvist SR Scand J Rheumatol; 1982; 11(1):23-6. PubMed ID: 6977838 [TBL] [Abstract][Full Text] [Related]
2. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases. Dequeker J; Decock T; Walravens M; Van de Putte I J Rheumatol; 1978; 5(4):452-9. PubMed ID: 739494 [TBL] [Abstract][Full Text] [Related]
3. [Seronegative spondylo-arthropathies and HLA-B27]. Kaludi M Union Med Can; 1984 Jun; 113(6):455-9, 521. PubMed ID: 6333098 [No Abstract] [Full Text] [Related]
4. The HLA system and the rheumatic diseases. Marcelli-Barge A; Legrand L; Poirier JC; Schmid M; Dausset J Eur J Rheumatol Inflamm; 1982; 5(4):406-22. PubMed ID: 6983960 [No Abstract] [Full Text] [Related]
5. [Diagnostic significance of the occurrence of tissue antigen HLA-B27 in various rheumatic diseases]. Kuthan F; Streda A; Parma R; Krepelková M; Hill Z; Valnícková Z Vnitr Lek; 1979 Jun; 25(6):578-3. PubMed ID: 313621 [No Abstract] [Full Text] [Related]
6. [Determination of HLA-B27 antigen. Indications and limitations]. Marcelli-Barge A; Poirier JC; Prévost P Presse Med; 1983 Apr; 12(15):931-3. PubMed ID: 6221245 [No Abstract] [Full Text] [Related]
7. [HLA-B27-related diseases and their pathogenesis]. Linssen A; Feltkamp TE Ned Tijdschr Geneeskd; 1987 Oct; 131(44):1955-9. PubMed ID: 3500421 [No Abstract] [Full Text] [Related]
9. Mortality in pacemaker-treated patients. A follow-up study of the impact of HLA B27 and associated rheumatic disorders. Bergfeldt L; Allebeck P; Edhag O Acta Med Scand; 1987; 222(4):293-9. PubMed ID: 3501228 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of HLA-B27 in Northern Norway. Gran JT; Mellby AS; Husby G Scand J Rheumatol; 1984; 13(2):173-6. PubMed ID: 6610933 [TBL] [Abstract][Full Text] [Related]
11. [Human leukocyte B27 antigen in patients with seronegative arthritis]. Mladenović V; Kecman-Prunić B; Susaković N; Stolić I Srp Arh Celok Lek; 1983 Jun; 111(6):733-40. PubMed ID: 6607538 [No Abstract] [Full Text] [Related]
12. [Ankylosing spondylitis, rheumatoid arthritis and HLA antigens in Chinese]. Zheng SQ Zhonghua Nei Ke Za Zhi; 1983 May; 22(5):285-7. PubMed ID: 6605236 [No Abstract] [Full Text] [Related]
13. Use of the HLA B27 test in Auckland. Thomas MG; Hart HH; Grigor RR; Gow PJ; Moore TE N Z Med J; 1984 Oct; 97(765):686-8. PubMed ID: 6333007 [TBL] [Abstract][Full Text] [Related]
14. [HLA B 27 uveitis in ankylosing spondylitis and reactive arthritis]. Dumbrăveanu L; Cuşnir V; Groppa L; Calinina L Oftalmologia; 2010; 54(1):29-35. PubMed ID: 20540366 [TBL] [Abstract][Full Text] [Related]
15. [B27-positive diseases. A new concept in rheumatology (author's transl)]. Schattenkirchner M; Krüger K; Herzer P MMW Munch Med Wochenschr; 1980 Nov; 122(48):1725-8. PubMed ID: 6779137 [TBL] [Abstract][Full Text] [Related]
16. TAP1 and TAP2 polymorphism in HLA-B27-positive subpopulations: no allelic differences in ankylosing spondylitis and reactive arthritis. Westman P; Partanen J; Leirisalo-Repo M; Koskimies S Hum Immunol; 1995 Dec; 44(4):236-42. PubMed ID: 8770637 [TBL] [Abstract][Full Text] [Related]
17. HSP70-Hom NcoI polymorphism and HLA-associations in the Finnish population and in patients with ankylosing spondylitis or reactive arthritis. Westman P; Partanen J; Leirisalo-Repo M; Koskimies S Eur J Immunogenet; 1994 Apr; 21(2):81-90. PubMed ID: 9098422 [TBL] [Abstract][Full Text] [Related]